FDA Approved Eye Drops: Lenz Therapeutics Launc...

By HEOR Staff Writer

August 11, 2025

LENZ Therapeutics has secured FDA approval for VIZZ (aceclidine ophthalmic solution) 1.44%. These are the first FDA-approved eye drops designed to treat presbyopia in adults. They offer a once-daily improvement of near vision for up to 10 hours, a...
DTC Telehealth Partnerships: Navigating Risks in Pharma’s Digital Expan...
NICE’s Ribociclib Breast Cancer Guidance: A New Era for High-Risk Patie...
Efficacy and Insights of Transdiagnostic Mental Health Apps for Depression an...
T1 Diabetes Care with an Implantable Glucose Device
Lenacapavir HIV Prevention: Gilead’s Strategic Agreement to Enhance Acc...
Revolutionizing Pediatric Care: Approval of Malaria Medicine for Newborns
How Gene-Editing Therapies Are Revolutionizing ASCVD Treatment and Market Tra...
EMA 2024 Report Highlights: Innovations in Medicine Approval and Regulatory A...
NICE Approves Transformative Multiple Myeloma Treatment
EHK Clusters 2026 Report: Enhancements in Dutch Risk Equalization for High-Co...
Pfizer Conference Insights: Analyzing Bourla’s Strategic Vision Amid Po...
Revitalizing Innovation: The Impact of UK Medicine Payment Rates